These findings provided a reliable evidence that p53 exhibited a beneficial effect on skeletal muscle by either promoting DNA repair through activation of RRM2B or ameliorating insulin resistance, which in turn mitigated the sarcopenia. This evidence concerns the gene TP53 and sarcopenia.